as on March 4, 2026 at 7:59 am IST
Day's Low
Day's High
0.67%
Downside
1.59%
Upside
52 Week's Low
52 Week's High
9.73%
Downside
44.57%
Upside
Check Harmony Biosciences Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
4.7941
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.55%
PE Ratio (TTM)
9.12
Industry PE ratio
7.914017857142857
PEG Ratio
0EBITDA
233.8M
Revenue (TTM)
868.5M
Profit Margin
18.27%
Return On Equity TTM
20.75%
Track how Harmony Biosciences Holdings Inc P/E has moved over time to understand its valuation trends.
Harmony Biosciences Holdings Inc in the last 5 years
Lowest (-14.38x)
March 31, 2021
Industry (7.91x)
March 4, 2026
Today (9.12x)
March 4, 2026
Highest (48.02x)
December 31, 2021
Today’s Price to Earnings Ratio: 9.12x
Compare market cap, revenue, PE, and other key metrics of Harmony Biosciences Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.7B | -14.39% | 9.12 | 18.27% | |
| BUY | $123.5B | 128.24% | 31.75 | 32.94% | |
| BUY | $43.1B | 131.96% | 138.92 | 8.45% | |
| NA | $34.8B | NA | 593.13 | 5.37% | |
| BUY | $83.6B | 70.6% | 19.05 | 31.41% |
The Harmony Biosciences Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Harmony Biosciences Holdings Inc investment value today
Current value as on today
₹92,196
Returns
Returns from Harmony Biosciences Holdings Inc Stock
Dollar Returns*
₹5,505 (+5.5%)
Based on 14 analysts
78.57%
Buy
7.14%
Hold
14.29%
Sell
Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Harmony Biosciences Holdings Inc. Average target price of $42
Get share price movements and forecasts by analysts on Harmony Biosciences Holdings Inc.
What analysts predicted
32.69%UPSIDE
Target Price
$42
Current Price
$28.27
Analyzed by
14 Analysts
Target
$42.00
Harmony Biosciences Holdings Inc target price $42, a slight upside of 32.69% compared to current price of $28.27. According to 14 analysts rating.
Investment in Harmony Biosciences Holdings Inc Shares on INDmoney has grown by 244.44% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:244.44% versus previous 30 day period
Search interest for Harmony Biosciences Holdings Inc Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:31% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 19 February
Thu, 06:04 PM
-Harmony Biosciences' 2026 EPS estimates rise from $3.72 to $4.00; shares down 3.7% over six months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 184.73M → 243.77M (in $), with an average increase of 8.6% per quarter
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 93.7%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.8% return, outperforming this stock by 45.2%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 50.86M → 22.48M (in $), with an average decrease of 55.8% per quarter
Price Dip
![]()
In the last 1 month, HRMY stock has moved down by -22.6%
| Organisation | Harmony Biosciences Holdings Inc |
| Headquarters | 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
| Industry | Health Technology |
| CEO | Dr. Jeffrey M. Dayno M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Jeffrey M. Dayno M.D. | President, CEO & Director |
Dr. Kumar Budur M.D., M.S. | Executive VP and Chief Medical & Scientific Officer |
Mr. Andrew Serafin J.D., M.B.A. | Executive VP & Chief Strategy Officer |
Brennan Doyle | VP & Head of Investor Relations |
Mr. Christian Ulrich J.D. | Executive VP, General Counsel & Corporate Secretary |
Ms. Audrey Murphy SPHR | Chief Human Resources Officer |
Mr. Jeffrey S. Aronin | Founder & Non-Executive Chairman |
Ms. Cate McCanless | Senior VP & Chief Corporate Affairs Officer |
Mr. Adam Zaeske | Executive VP & Chief Commercial Officer |
Ms. Tricia Glover | Chief Compliance Officer |
Harmony Biosciences Holdings Inc share price today is $28.27 as on at the close of the market. Harmony Biosciences Holdings Inc share today touched a day high of $28.72 and a low of $28.08.
Harmony Biosciences Holdings Inc share touched a 52 week high of $40.87 on and a 52 week low of $25.52 on . Harmony Biosciences Holdings Inc stock price today i.e. is closed at $28.27,which is 30.83% down from its 52 week high and 10.78% up from its 52 week low.
Harmony Biosciences Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Harmony Biosciences Holdings Inc (HRMY) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Harmony Biosciences Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Harmony Biosciences Holdings Inc share’s latest price of $28.27 as on March 4, 2026 at 2:29 am IST, you will get 0.3537 shares of Harmony Biosciences Holdings Inc. Learn more about
fractional shares .
Harmony Biosciences Holdings Inc stock has given -14.39% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?